RDY logo

RDY

Profile

Full Name

Dr. Reddy's Laboratories Limited

Ticker Symbol

RDY

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

India

IPO

April 11, 2001

Indexes

Not included

Website

http://www.drreddys.com

Employees

27048

Key Details

Price

$13.25(+0.23%)

Market cap

Last Dividend

$0.10

TTM Dividend yield

0.72%

Annual revenue

$3.37B(+9.96% YoY)

Annual EPS

$0.81(+19.45% YoY)

PE ratio

31.14

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.25
RDY price is $13.25

30-Day Relative Volume

1.20
RDY 30-day relative volume is 1.20

Price Performance

Price Most recent change

+0.23%
RDY price was up +0.23% on Apr 14, 2025

Price YTD change

-16.09%
RDY price is down -16.09% since January 1st

Price 1-year change

-6.85%
RDY price is down -6.85% year-on-year

Price 3-year change

+18.28%
RDY price is up +18.28% over the past 3 years

Price Range

Price All-time high

$84.46
RDY price is currently -84.31% below its historical high of $84.46

Price 3-year low

$9.92
RDY price is currently +33.51% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.04B
RDY market capitalization is $11.04 billion

Market cap 3-year change

+18.76%
RDY market capitalization is up +18.76% over the past 3 years

Market cap All-time high

$14.03B
RDY market capitalization is currently -21.30% below its historical high of $14.03 billion

Market cap sector rank

93.17%
RDY market capitalization is higher than 93.17% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.06%
RDY shares outstanding is up +0.06% year-on-year

Shares Outstanding 3-Year Change

+0.41%
RDY shares outstanding is up +0.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.45
RDY beta is 0.45

200-day SMA

$14.89
RDY price is currently -11.04% below its 200-day simple moving average

50-day SMA

$13.23
RDY price is currently +0.13% above its 50-day simple moving average

RSI

52.66
RDY 14-day relative strength index is 52.66

Volume

1.20
RDY 30-day relative volume is 1.20

ATR

$0.36
RDY average true range is $0.36

10-day Historical Volatility

51.14%
RDY 10-day historical volatility is 51.14%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.10
RDY last dividend was $0.10 per share, with an ex-dividend date of July 30, 2024

Next Dividend

-
RDY next dividend has not yet been announced

Dividend per share

Dividend per share

$0.10
RDY annual dividend per share is $0.10

Dividend per share Sector Rank

4.65%
RDY annual dividend per share is higher than 4.65% of companies in Healthcare sector

Dividend per share 1-Year Change

+27.48%
RDY annual dividend per share is up +27.48% year-on-year

Dividend per share 3-Year Change

+44.68%
RDY annual dividend per share is up +44.68% over the past 3 years

Dividend yield

Dividend yield

0.73%
RDY annual dividend yield is 0.73%

Dividend yield Sector Rank

21.18%
RDY annual dividend yield is higher than 21.18% of companies in Healthcare sector

Other

Payout ratio

11.94%
RDY annual payout ratio is 11.94%

Dividends paid

$80.31M
RDY annual dividends paid is $80.31 million

Free cash flow

$217.41M
RDY annual free cash flow is $217.41 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.37B
RDY annual revenue is $3.37 billion

Revenue Analysts estimate

$323.36B
RDY annual revenue is currently -98.96% lower than the consensus analysts' forecast

Revenue 1-year change

+9.96%
RDY annual revenue is up +9.96% year-on-year

Revenue Sector rank

89.7%
RDY annual revenue is higher than 89.7% of companies in Healthcare sector

EPS

EPS

$0.81
RDY annual earnings per share is $0.81

EPS Analysts estimate

$70.93
RDY annual earnings per share is currently -98.86% lower than the consensus analysts' forecast

EPS 1-year change

+19.45%
RDY annual earnings per share is up +19.45% year-on-year

EPS Sector rank

88.59%
RDY annual earnings per share is higher than 88.59% of companies in Healthcare sector

Profit

Gross profit

$2.38B
RDY annual gross profit is $2.38 billion

Gross margin

70.60%
RDY annual gross profit margin is 70.60%

Operating profit

$780.75M
RDY annual operating income is $780.75 million

Operating margin

23.15%
RDY annual operating profit margin is 23.15%

Net income

$672.64M
RDY annual net profit is $672.64 million

Net margin

19.98%
RDY annual net profit margin is 19.98%

Expenses

Total expenses

$2.59B
RDY annual total expenses is $2.59 billion

Operating expenses

$1.60B
RDY annual total operating expenses is $1.60 billion

Cost of goods sold

$991.58M
RDY annual cost of goods sold is $991.58 million

Selling, general & administrative expenses

$1.43B
RDY annual SGA is $1.43 billion

Depreciation and amortization

$177.57M
RDY annual depreciation & amortization is $177.57 million

Interest expense

$20.67M
RDY annual interest expense is $20.67 million

Income tax

$196.06M
RDY annual income tax is $196.06 million

EBIT & EBITDA

EBIT

$890.52M
RDY annual earnings before interest & taxes is $890.52 million

EBITDA

$1.07B
RDY annual EBITDA is $1.07 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.65B
RDY annual total assets is $4.65 billion

Non current assets

$1.69B
RDY annual long term assets is $1.69 billion

Current assets

$2.97B
RDY annual total current assets is $2.97 billion

Cash and cash equivalents

$85.22M
RDY annual cash & cash equivalents is $85.22 million

Accounts receivable

$962.85M
RDY annual accounts receivable is $962.85 million

Inventory

$762.05M
RDY annual inventory is $762.05 million

Liabilities

Total liabilities

$1.28B
RDY annual total liabilities is $1.28 billion

Long term liabilities

$122.43M
RDY annual total long term liabilities is $122.43 million

Current liabilities

$1.15B
RDY annual total current liabilities is $1.15 billion

Accounts payable

$313.49M
RDY annual accounts payable is $313.49 million

Debt

Total debt

$240.06M
RDY annual total debt is $240.06 million

Total debt 1-year change

+46.3%
RDY annual total debt is up +46.3% year-on-year

Long term debt

$71.83M
RDY annual long term debt is $71.83 million

Short term debt

$168.23M
RDY annual short term debt is $168.23 million

Equity & Capital

Shareholders equity

$3.36B
RDY annual stockholders equity is $3.36 billion

Book value

$3.39B
RDY annual book value is $3.39 billion

Retained earnings

$3.18B
RDY annual retained earnings is $3.18 billion

Working capital

$1.82B
RDY annual working capital is $1.82 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$548.81M
RDY annual cash flow from operations is $548.81 million

Cash from operations 1-year change

-25.26%
RDY annual cash flow from operations is down -25.26% year-on-year

Cash from investing

-$486.60M
RDY annual cash flow from investing activities is -$486.60 million

Cash from investing 1-year change

+5.7%
RDY annual cash flow from investing activities is up +5.7% year-on-year

Cash from financing

-$45.46M
RDY annual cash flow from financing activities is -$45.46 million

Cash from financing 1-year change

+86.43%
RDY annual cash flow from financing activities is up +86.43% year-on-year

CAPEX

CAPEX

$331.40M
RDY annual capital expenditures is $331.40 million

CAPEX 1-year change

+40.84%
RDY annual capital expenditures is up +40.84% year-on-year

Free Cash Flow

Free cash flow

$217.41M
RDY annual free cash flow is $217.41 million

Free cash flow 1-year change

-56.43%
RDY annual free cash flow is down -56.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

70.60%
RDY annual gross profit margin is 70.60%

Operating margin

23.15%
RDY annual operating profit margin is 23.15%

Net margin

19.98%
RDY annual net profit margin is 19.98%

ROA & ROE

ROA

15.70%
RDY annual return on assets is 15.70%

ROE

21.78%
RDY annual return on equity is 21.78%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

31.14
RDY price to earnings ratio is 31.14

PE ratio Sector rank

62.25%
RDY price to earnings ratio is higher than 62.25% of companies in Healthcare sector

PB Ratio

PB ratio

2.98
RDY price to book ratio is 2.98

PB ratio Sector rank

72.18%
RDY price to book ratio is higher than 72.18% of companies in Healthcare sector

PS Ratio

PS ratio

3.94
RDY price to sales ratio is 3.94

PS ratio Sector rank

60.26%
RDY price to sales ratio is higher than 60.26% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.49B
RDY enterprise value is $11.49 billion

Enterprise value Sector rank

93.06%
RDY enterprise value is higher than 93.06% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.06
RDY EV/EBITDA is 14.06

EV/EBITDA Sector rank

87.3%
RDY EV/EBITDA is higher than 87.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.59
RDY annual current ratio is 2.59

Quick ratio

1.92
RDY annual quick ratio is 1.92

Leverage

Debt to equity

0.06
RDY annual debt to equity ratio is 0.06

Interest coverage ratio

43.09
RDY annual interest coverage ratio is 43.09

Risk & Stability

Piotroski F-Score

4
RDY piotroski f-score is 4

Altman Z-Score

7.95
RDY altman z-score is 7.95

Analyst ratings

Recent major analysts updates

Nov 6, 24 Barclays
Overweight
Jul 30, 24 Barclays
Overweight
May 8, 24 Barclays
Overweight
Jan 29, 24 Barclays
Overweight
Jun 1, 23 Barclays
Overweight
Oct 31, 22 Barclays
Overweight
Oct 25, 22 Barclays
Overweight
Sep 12, 22 Barclays
Overweight
Jul 25, 22 Barclays
Overweight
May 24, 22 Barclays
Overweight

Institutional Ownership

Similar stocks

SNN logo
Smith & Nephew (SNN)
BMRN logo
BioMarin Pharmaceutical (BMRN)
INCY logo
Incyte (INCY)
AVTR logo
Avantor (AVTR)
UHS logo
Universal Health Services (UHS)
PEN logo
Penumbra (PEN)
EHC logo
Encompass Health (EHC)
MRNA logo
Moderna (MRNA)
SOLV logo
Solventum (SOLV)
  • What is the ticker symbol for Dr Reddys Laboratories Limited?
  • Does Dr Reddys Laboratories Limited pay dividends?
  • What sector is Dr Reddys Laboratories Limited in?
  • What industry is Dr Reddys Laboratories Limited in?
  • What country is Dr Reddys Laboratories Limited based in?
  • When did Dr Reddys Laboratories Limited go public?
  • Is Dr Reddys Laboratories Limited in the S&P 500?
  • Is Dr Reddys Laboratories Limited in the NASDAQ 100?
  • Is Dr Reddys Laboratories Limited in the Dow Jones?
  • When was Dr Reddys Laboratories Limited's last earnings report?
  • When does Dr Reddys Laboratories Limited report earnings?

What is the ticker symbol for Dr Reddys Laboratories Limited?

The ticker symbol for Dr Reddys Laboratories Limited is NYSE:RDY

Does Dr Reddys Laboratories Limited pay dividends?

Yes, Dr Reddys Laboratories Limited pays dividends. The last payment was $0.10, with an ex-dividend date on July 30, 2024

What sector is Dr Reddys Laboratories Limited in?

Dr Reddys Laboratories Limited is in the Healthcare sector

What industry is Dr Reddys Laboratories Limited in?

Dr Reddys Laboratories Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Dr Reddys Laboratories Limited based in?

Dr Reddys Laboratories Limited is headquartered in India

When did Dr Reddys Laboratories Limited go public?

Dr Reddys Laboratories Limited's initial public offering (IPO) was on April 11, 2001

Is Dr Reddys Laboratories Limited in the S&P 500?

No, Dr Reddys Laboratories Limited is not included in the S&P 500 index

Is Dr Reddys Laboratories Limited in the NASDAQ 100?

No, Dr Reddys Laboratories Limited is not included in the NASDAQ 100 index

Is Dr Reddys Laboratories Limited in the Dow Jones?

No, Dr Reddys Laboratories Limited is not included in the Dow Jones index

When was Dr Reddys Laboratories Limited's last earnings report?

Dr Reddys Laboratories Limited's most recent earnings report was on Jan 23, 2025

When does Dr Reddys Laboratories Limited report earnings?

The next expected earnings date for Dr Reddys Laboratories Limited is May 7, 2025
On this page